High-definition surface electromyography to diagnose and monitor sarcopenia
Official title: Preventing Loss of Autonomy in Older Patients by Improving Diagnosis of Sarcopenia and Monitoring With High-definition Surface Electromyography Technology
Run by Assistance Publique - Hôpitaux de Paris · NCT06963359 · Data updated 2026-11-12
This project will try high-definition surface electromyography (HD-sEMG) to see if it can diagnose and monitor sarcopenia in people aged 75 and older who score ≥4 on the SARC-F screening questionnaire.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 846 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 11 sites (Issy-les-Moulineaux and 10 other locations) |
| Status | Recruiting |
| Started | July 9, 2025 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT06963359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 75 or older hospitalized in acute geriatric or rehabilitation wards who score ≥4 on the SARC-F and meet the study's inclusion and exclusion criteria.
✕Probably not a fit
Patients with BMI ≥30, pacemakers, bilateral hip prostheses, severe cognitive impairment or psychiatric disease preventing tests, very short life expectancy, skin allergies that prevent electrode use, or those under state medical aid (AME) are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, descriptive, cross-sectional, parallel-group study plans to enroll 846 patients aged 75 and over hospitalized in acute geriatric or rehabilitation wards who screen positive for sarcopenia (SARC-F ≥4). Investigators will record HD-sEMG signals and extract features to develop diagnostic markers, alongside quadriceps ultrasound, body composition by bioelectrical impedance (and DEXA when available), grip strength, and the IPAQ physical activity questionnaire. Inclusion is planned over 18 months with an additional 3-month follow-up, and the team aims to build an automatic procedure combining functional and morphological muscle data. The study is coordinated by Assistance Publique–Hôpitaux de Paris across multiple AP-HP hospital sites.
Why it matters
Potential benefit: If successful, HD-sEMG could provide a non-invasive, bedside tool to detect and monitor sarcopenia earlier and more routinely than current imaging-based methods.
How similar studies have gone: Conventional surface EMG has been used to study muscle activity, but applying high-definition sEMG specifically for sarcopenia diagnosis and monitoring is relatively novel with limited clinical validation so far.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 75 years and over * Score ≥4 on the SARC-F screening questionnaire * Enrolled in a social security plan (no AME) * Informed and consenting patient Exclusion Criteria: * BMI ≥30 kg/m2 * Severe psychiatric pathology or severe cognitive disorders that do not allow the performance of examinations * Patients who are dependent for all acts of daily life * Patients with a very short life expectancy \<3months * Pace maker * Recent fracture or trauma of the preventing dynamic measurement of HD-sEMG recording * Bilateral hip prosthesis * Skin problem that may interfere with the recording of surface EMG activity * Skin allergies to plasters * Allergies to electrode materials (acrylate) * Patient under legal protection * Patient on state medical aid (AME : Aide Médicale d'Etat)
Where it's running
-
Hôpital Corentin Celton, APHP
Issy-les-Moulineaux, France Recruiting -
Hôpital Corentin Celton, APHP
Issy-les-Moulineaux, France Recruiting -
Hôpital Charles Foix, APHP
Ivry-sur-Seine, France Recruiting -
Hôpital Charles Foix, APHP
Ivry-sur-Seine, France Recruiting -
Hôpital Charles Foix, APHP
Ivry-sur-Seine, France Recruiting -
Hôpital Rothschild, APHP
Paris, France Recruiting
Show 5 more locations
-
Hôpital Rothschild, APHP
Paris, France Recruiting -
Hôpital Saint-Antoine, APHP
Paris, France Recruiting -
Hôpital Bichat, APHP
Paris, France Recruiting -
Hôpital Tenon, APHP
Paris, France Recruiting -
Unité d'Explorations fonctionnelles du sujet âgé - Hôpital Charles Foix
Ivry-sur-Seine, France Not yet recruiting
Study contacts
- Study coordinator: Kiyoka KINUGAWA, Prof. MD PhD
- Email: kiyoka.kinugawa@aphp.fr
- Phone: +331 49 59 47 53
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.